{"id":"W7021062038","doi":"","title":"Nabriva Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights","year":2017,"lang":"en","type":"other","venue":"","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Payment; Work (physics); Financial Audit","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001965337,0.0008963972,0.0005430831,0.001493533,0.0009598246,0.005054235,0.001123773,0.002977073,0.2972451],"category_scores_gemma":[0.003125627,0.0002494976,0.0006902412,0.0009099889,0.0007702784,0.001918907,0.001608127,0.00304558,0.1941202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002332647,"about_ca_system_score_gemma":0.006343534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002037852,"about_ca_topic_score_gemma":0.004175735,"domain_scores_codex":[0.9981614,0.00009981688,0.00004835648,0.0001213261,0.001249604,0.0003195017],"domain_scores_gemma":[0.9972984,0.0002222657,0.0001906004,0.0001356097,0.00114379,0.001009286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001005951,0.0001414073,0.0001792826,0.00009811558,0.000006472226,0.0001053377,0.00001039604,0.00009460668,0.0005087925,0.004914341,0.9226931,0.07114752],"study_design_scores_gemma":[0.00003756264,0.00005921805,0.0004401732,0.00008127378,0.000005098393,0.0001036996,0.00001954125,0.0001611855,0.000691604,0.001205761,0.9971882,0.000006790196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.001679671,0.008052601,0.0007014202,0.02887594,0.01627489,0.0002238605,0.002507592,0.000707969,0.9409761],"genre_scores_gemma":[0.004268629,0.005657994,0.0003019354,0.0029987,0.00381889,0.00005432778,0.001530362,0.0001732872,0.9811959],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.7027549,"threshold_uncertainty_score":0.9943839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1381170495177368,"score_gpt":0.4023041556263717,"score_spread":0.2641871061086349,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}